Semaglutide API prices are falling sharply as global demand for weight-loss drugs like Ozempic and Wegovy drives rapid manufacturing expansion. With patents set to expire in key markets and Indian companies rolling out lower-priced generics, analysts expect additional price softening. The shift could widen access to these GLP-1 therapies for patients in the months ahead.
Gurugram law enforcement has reportedly dismantled a counterfeit Mounjaro operation, placing two people in custody. Authorities say the ring imported raw materials from China and manufactured the injections at a private home, supplying illicit diabetes and obesity drugs. Eli Lilly issued a statement after the Gurugram drug racket was exposed, underscoring growing concerns about counterfeit GLP-1 medications.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
